A detailed history of Dsc Advisors, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Dsc Advisors, L.P. holds 50,550 shares of ABT stock, worth $5.25 Million. This represents 9.51% of its overall portfolio holdings.

Number of Shares
50,550
Previous 72,889 30.65%
Holding current value
$5.25 Million
Previous $8.02 Million 28.38%
% of portfolio
9.51%
Previous 13.62%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $2.45 Million - $2.7 Million
-22,339 Reduced 30.65%
50,550 $5.75 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $288,517 - $353,169
3,199 Added 4.59%
72,889 $8.02 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $2.7 Million - $3.24 Million
28,275 Added 68.27%
69,690 $6.75 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $4.17 Million - $4.65 Million
41,415 New
41,415 $4.52 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $94,437 - $109,341
-976 Reduced 29.48%
2,335 $226,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $16,331 - $19,739
-160 Reduced 4.61%
3,311 $360,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $183,686 - $223,993
1,611 Added 86.61%
3,471 $411,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $22,412 - $27,443
-194 Reduced 9.44%
1,860 $262,000
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $13,182 - $14,583
113 Added 5.82%
2,054 $243,000
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $117,215 - $137,979
-1,108 Reduced 36.34%
1,941 $225,000
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $331,853 - $390,973
3,049 New
3,049 $365,000
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $212,835 - $231,929
-2,027 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $185,754 - $225,584
2,027 New
2,027 $221,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $300,970 - $440,101
-4,791 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $70,659 - $78,660
900 Added 23.13%
4,791 $416,000
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $53,523 - $58,035
654 Added 20.2%
3,891 $326,000
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $20,552 - $23,970
-282 Reduced 8.01%
3,237 $272,000
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $662 - $800
10 Added 0.28%
3,519 $281,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $230,050 - $260,613
3,509 New
3,509 $254,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dsc Advisors, L.P. Portfolio

Follow Dsc Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Dsc Advisors, L.P. with notifications on news.